LOAN AGREEMENTLoan Agreement • February 28th, 2018 • TESARO, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2018 Company Industry JurisdictionTHIS LOAN AGREEMENT (this “Agreement”), dated as of November 21, 2017 (the “Effective Date”) by and among TESARO, INC., a Delaware corporation (as “Borrower”), TESARO SECURITIES CORPORATION, a Massachusetts corporation (as an additional Credit Party), BIOPHARMA CREDIT PLC, a public limited company incorporated under the laws of England and Wales (as “Collateral Agent” and a “Lender”) and BIOPHARMA CREDIT INVESTMENTS IV SUB LP, a Cayman Islands limited partnership (as a “Lender”), provides the terms on which each Lender shall make, and Borrower shall repay, the Credit Extensions (as hereinafter defined). The parties hereto agree as follows:
SEVENTH AMENDMENT TO LEASELease • February 28th, 2018 • TESARO, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2018 Company IndustrySEVENTH AMENDMENT TO LEASE (this “Seventh Amendment”) dated as of this 10th day of October, 2017 (the “Seventh Amendment Effective Date”) by and between BP BAY COLONY LLC, a Delaware limited liability company (“Landlord”), and TESARO, INC., a Delaware corporation (“Tenant”).
BAY COLONY CORPORATE CENTER WALTHAM, MASSACHUSETTS Lease Dated December 18, 2017Work Agreement • February 28th, 2018 • TESARO, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 28th, 2018 Company Industry JurisdictionTHIS INSTRUMENT IS AN INDENTURE OF LEASE in which the Landlord and the Tenant are the parties hereinafter named, and which relates to space in a certain building (the “Building”) known as, and with an address at, 1100 Winter Street, Waltham, Massachusetts 02451.
Collaboration, Development and License AgreementDevelopment and License Agreement • February 28th, 2018 • TESARO, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2018 Company Industry JurisdictionTHIS AMENDMENT TO COLLABORATION, DEVELOPMENT AND LICENSE AGREEMENT (the “Amendment”) is made and entered into as of February 26, 2018 by and among TESARO, Inc., a Delaware corporation (“TESARO Inc.”), TESARO Development Ltd., a Bermuda corporation (“TSRO Ltd.” and together with TESARO Inc., “TESARO”), and Zai Lab (Shanghai) Co., Ltd., a limited liability company organized under the laws of the People’s Republic of China (“Zai” and together with TESARO, the “Parties”).
FIRST AMENDMENT TO LOAN AGREEMENTLoan Agreement • February 28th, 2018 • TESARO, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2018 Company Industry JurisdictionThis First Amendment to the Loan Agreement (defined below) (this “Amendment”), dated as of February 7, 2018 (the “Effective Date”), is entered into by and among TESARO, INC., a Delaware corporation (as “Borrower”), TESARO SECURITIES CORPORATION, a Massachusetts corporation (as an additional Credit Party), BIOPHARMA CREDIT PLC, a public limited company incorporated under the laws of England and Wales (as “Collateral Agent” and a “Lender”) and BIOPHARMA CREDIT INVESTMENTS IV SUB LP, a Cayman Islands limited partnership (as a “Lender”).